Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

L. Mann, Douglas; J.V. McMurray, John; Packer, Milton; Swedberg, Karl; Borer, Jeffrey; S. Colucci, Wilson; Djian, Jacques; Drexler, Helmut; M. Feldman, Arthur; Køber, Lars; Krum, Henry; Liu, Peter; S. Nieminen, Markku; Tavazzi, Luigi; Jan van Veldhuisen, Dirk; Waldenström, Anders; Warren, Marshelle; Westheim, Arne; Zannad, Faı̈ez; R. Fleming, Thomas

doi:10.1161/01.cir.0000124490.27666.b2

Public

Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

Published in Circulation • Mar 16, 2004

Authors:

Douglas L. Mann

John J.V. McMurray

Milton Packer

Abstract

BACKGROUND: Studies in experimental models and preliminary clinical experience suggested a possible therapeutic role for the soluble tumor necrosis factor antagonist etanercept in heart failure. METHODS AND RESULTS: Patients with New York Heart Association class II to IV chronic heart failure and a ...

Subject

Etanercept

Medicine

Heart failure

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!